Jean Lucien Rouleau
Université de Montréal
4 papers in the Anchorcite directory, published between 1992 and 2014, cited 25,476 times in total.
ORCID profileResearch topics
- Lipoproteins and Cardiovascular Health · 2 papers
- Acute Myocardial Infarction Research · 2 papers
- Cancer, Lipids, and Metabolism · 2 papers
- Renin-Angiotensin System Studies · 2 papers
- Heart Failure Treatment and Management · 2 papers
- Heart rate and cardiovascular health · 1 paper
Frequent co-authors
- Marc Alan Pfeffer · 3 papers
- Eugene Braunwald · 3 papers
- Lemuel A. Moyé · 2 papers
- John D. Rutherford · 2 papers
- Barry R. Davis · 2 papers
- Milton Packer · 2 papers
- Frank M. Sacks · 1 paper
- Thomas G. Cole · 1 paper
Papers
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine · 1996 · 7,419 citations
BACKGROUND: In patients with high cholesterol levels, lowering the cholesterol level reduces the risk of coronary events, but the effect of lowering cholesterol levels in the majority of patients with coronary disease, who have average levels, is less clear. METHODS:…
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart FailureNew England Journal of Medicine · 2014 · 7,166 citations
BACKGROUND: We compared the angiotensin receptor-neprilysin inhibitor LCZ696 with enalapril in patients who had heart failure with a reduced ejection fraction. In previous studies, enalapril improved survival in such patients. METHODS: In this double-blind trial, we randomly assigned 8442 patients…
- Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine · 1992 · 5,925 citations
BACKGROUND: Left ventricular dilatation and dysfunction after myocardial infarction are major predictors of death. In experimental and clinical studies, longterm therapy with the angiotensin-converting--enzyme inhibitor captopril attenuated ventricular dilatation and remodeling. We investigated whether captopril could reduce morbidity and mortality…
- Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary SyndromesNew England Journal of Medicine · 2004 · 4,966 citations
BACKGROUND: Lipid-lowering therapy with statins reduces the risk of cardiovascular events, but the optimal level of low-density lipoprotein (LDL) cholesterol is unclear. METHODS: We enrolled 4162 patients who had been hospitalized for an acute coronary syndrome within the preceding 10…
Metadata from OpenAlex (CC0).